Here's Why You Should Retain Stryker Stock in Your Portfolio for Now
Stryker(SYK) ZACKS·2024-12-17 13:45
Stryker (SYK) is well-poised for growth, backed by a robust robotic arm-assisted surgery platform, Mako, and a diversified product portfolio. An improvement in price also buoys optimism.Shares of this Zacks Rank #3 (Hold) company have risen 24.5% year to date compared with the industry’s 11.5% growth. The S&P 500 Index has increased 27.8% in the same time frame.Stryker, with a market capitalization of $142.8 billion, is one of the world’s largest medical device companies operating in the orthopedic market. ...